The largest database of trusted experimental protocols

9 protocols using luciferase cell lysis buffer

1

Mismatch Repair Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assay was designed as previously described17 (link), with some adjustments. In short, we
digested our synthesized pLCMV-NanoLuc plasmid with NheI and PflFI to remove the
NanoLuc start codon region. We then ligated in annealed oligos containing a G-G
mismatch in the third position of the NanoLuc start codon; this was referred to
as our “Mismatch plasmid.” A set of annealed oligos with a WT
start codon was also ligated in to be used as a normalization control. The
annealed oligos also contained a disrupted HpaI restriction site, allowing us to
specifically eliminate any uncut parental pLCMV-NanoLuc plasmid (which contains
an intact HpaI site directly upstream of start codon) following plasmid
ligation. Validation of the MMR activity assay was done using A549 cells
transfected with MSH2 and MSH6 siRNA. For the comparison of A549 and H441 cells,
the cells were infected at MOI=10, transfected with 0.5 μg of the WT or
Mismatch plasmid at 24 hpi, and then analyzed at 16 h post-transfection. To
measure NanoLuc expression, cells were lysed with Luciferase Cell Lysis Buffer
(NEB) and then evaluated using the Nano-Glo Luciferase Assay Reagent Kit
(Promega).
+ Open protocol
+ Expand
2

HeLa Cell Transfection and Infection Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection experiments, HeLa Ohio cells were cotransfected in 24-well plates with pCMV-GLuc 2- and pRK5-Myc-derived plasmids at a ratio of 1:3 for 24 h. For infection experiments, HeLa Ohio cells stably expressing Gaussia luciferase (HeLa-Gluc) were plated at a density of 0.2 × 106 cells per well in a 24-well plate, and each time point was performed in triplicate. Cells were infected with HRV16 at an MOI of 20 for 1 h at room temperature and then washed in PBS before adding fresh medium and starting a 7-h time course. During the infection time course, culture medium was removed and replaced every 30 min and cells collected every 1 h. As controls, HeLa-Gluc cells either were not infected with virus or were not infected but treated with brefeldin A (BFA) at a final concentration of 5 μg/ml. To determine the Gluc activity in the cells, the wells were washed with PBS and the cells lysed in 250 μl of luciferase cell lysis buffer (B3321; New England BioLabs). Gluc secreted in the media and remaining in the cells was assayed using the BioLux Gaussia luciferase flex assay kit (E3308S; New England BioLabs) according to the manufacturer's instructions. Luminescence was analyzed on a FLUOstar OMEGA plate reader (BMG Labtech) as recommended. Each time point was determined in triplicate, and the experiment was performed independently three times.
+ Open protocol
+ Expand
3

Generating Luciferase-Expressing LN-229 Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
For tumor bioimaging, the LN-229 cell line was transduced with a pLACMV-Luc-puro lentiviral construct expressing firefly luciferase in the form of lentiviral particles. Following the transduction, the cells were selected in the medium containing 1 μg/mL of puromycin. To assess the transduction efficiency, LN-229 and LN-229-LucPuro cells were lysed with Luciferase Cell Lysis Buffer (NEB, Ipswich, MA, USA) and incubated for 20 min, followed by the addition of 100 μL luciferin solution (40 mg/mL) and luminescence measurement.
+ Open protocol
+ Expand
4

Transfection and Luciferase Assay in CHO and MEF Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO cells were transfected with Lipofectamin reagent 24 h after seeding following manufacturer’s instructions. Plasmids expressing the split-luciferase proteins were cotransfected in a 1:1 ratio. The control plasmid (Mock) was the corresponding empty vector. MEF cells (PS+/+ and PS−/−) were transfected using Trans-IT2020 according to the manufacturer’s instructions. CHO cells were treated with DAPT for 15 h at a final concentration of 1 μM. 48 h after transfection, medium was collected, treated with protease inhibitors cocktail (Roche) and stored at 20 °C for ECLIA assay. Cells were harvested and lysed in Luciferase Cell Lysis Buffer (New England Biolab) and pelleted by quick centrifugation at 4 °C for 1 min. Protein concentrations of cell lysates were measured by the BCA protein assay kit (Pierce). Cell lysates were further used for Gaussia luciferase assay and Western blotting.
+ Open protocol
+ Expand
5

Measuring Gluc and Fluc Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gluc activity was measured by adding 50 μl Gluc assay reagent (Nanolight Technology, Pinetop, AZ, USA) to 20 μl of the Gluc sample and analyzing with a GLOMAX 96 microporous plate light reader (Promega, Madison, WI, USA) to determine the bioluminescence. Fluc activity was similarly analyzed: 20 μl luciferase cell lysis buffer (NEB, Ipswich, MA, USA) was added to cellular extract, and then 100 μl of the Fluc assay reagent (Lulong, Xiamen, China) was added to the cell lysate and read immediately.
+ Open protocol
+ Expand
6

Mismatch Repair Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assay was designed as previously described17 (link), with some adjustments. In short, we
digested our synthesized pLCMV-NanoLuc plasmid with NheI and PflFI to remove the
NanoLuc start codon region. We then ligated in annealed oligos containing a G-G
mismatch in the third position of the NanoLuc start codon; this was referred to
as our “Mismatch plasmid.” A set of annealed oligos with a WT
start codon was also ligated in to be used as a normalization control. The
annealed oligos also contained a disrupted HpaI restriction site, allowing us to
specifically eliminate any uncut parental pLCMV-NanoLuc plasmid (which contains
an intact HpaI site directly upstream of start codon) following plasmid
ligation. Validation of the MMR activity assay was done using A549 cells
transfected with MSH2 and MSH6 siRNA. For the comparison of A549 and H441 cells,
the cells were infected at MOI=10, transfected with 0.5 μg of the WT or
Mismatch plasmid at 24 hpi, and then analyzed at 16 h post-transfection. To
measure NanoLuc expression, cells were lysed with Luciferase Cell Lysis Buffer
(NEB) and then evaluated using the Nano-Glo Luciferase Assay Reagent Kit
(Promega).
+ Open protocol
+ Expand
7

Hypoxia-induced transcriptional regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Spry1 promoter region (–341 to +39 bp relative to the transcription start site [TSS]) and a Pdk3 promoter region (–107 to +101 bp relative to the TSS) were PCR amplified from genomic DNA (C57BL/6 male) and subcloned into pGL4.18 (Promega). pGL4.18_Atp7a has been reported previously (35 (link)). pGL4.18-Spry1, pGL4.18-Atp7a, and pGL4.18-Pdk3 (200 ng each) were cotransfected with pcDNA3-HIF1ATM, pcDNA3-HIF2ATM, or a control empty pcDNA3 plasmid (200 ng) into C2C12 myoblasts. pcDNA-LacZ (100 ng) expressing β-gal was cotransfected as an internal transfection control. Forty-eight hours after transfection, myoblasts were lysed with Luciferase Cell Lysis Buffer (NEB), followed by a firefly luciferase/β-gal assay with homemade luciferase and β-gal solutions. The luciferase assay solution consisted of 0.11 M Trizma, pH7.8, 0.5 M MgCl2, 0.1 M ATP, and 10 mM luciferin. The β-gal solution consisted of 4 mg/ml O-nitrophenyl-β-D-galactoside, 60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, and 1 mM MgSO4.
+ Open protocol
+ Expand
8

Quantification of Lung Luciferase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
ODD-Luc mice were infected and euthanized as described above, and lungs and spleens were collected. Lungs were homogenized with DPBS and protease inhibitor (Roche), and an aliquot was reserved for luciferase quantification. Luciferase cell lysis buffer (New England Biolabs, Ipswich, MA) was added to form a homogenate, and the reaction mixture was incubated at room temperature for 15 min. Protein concentrations were quantified using the bicinchoninic acid (BCA) assay (Thermo, Fisher). Thirty micrograms of protein was added to an opaque Corning 96-well plate (Corning, NY), and luciferase buffer was added using a BioTek Synergy multimode plate reader (BioTek). Luciferase buffer was composed of 4.8 ml 0.11 mM Tris (pH 7.8), 50 µl 100 mM sodium luciferin, 60 µl 200 mM ATP, and 120 µl 0.5 M MgCl2.
+ Open protocol
+ Expand
9

Quantitative Gaussia Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cell extracts equivalent to 1 × 106 cells were separated on SDS-polyacrylamide gels and subject to either standard or LICOR western blotting analysis according to the manufacturers’ instructions. For standard western blots, duplicate gels were generated and one was stained with Coomassie and the other was used to produce the nitrocellulose blot. Blots were blocked in 5% milk in TBST and washes were performed in TBST (0.05% Tween). Blots were then probed with 1/1000 α-gLUC primary antibody (New England Biolabs) and 1/2000 α-rabbit secondary antibody (Bio-Rad). For LICOR blots, blocking was performed in 50 mM Tris, pH 7.4, 0.15 M NaCl, 0.25% BSA, 0.05% Tween, 2% fish skin gelatine (Sigma, UK) and washes were performed in TBST (α-gLUC) or PBST (α-GFP). Nitrocellulose blots were incubated with 1/1000 α-gLUC or 1/5000 α-GFP (Life Technologies) and 1/20 α-tubulin (kind gift from Keith Gull), followed by 1/10,000 α-mouse and 1/10,000 α-rabbit IR Dye antibodies (LICOR). Lysates for gLUC assays were prepared by adding 20 µl of 1 × luciferase cell lysis buffer (New England Biolabs) to 2 × 106 pelleted cells and these were directly used to perform BioLux Gaussia luciferase assays (New England Biolabs) according to the manufacturers’ instructions and using a TopCount plate-reader with white-walled plates. One-way ANOVA tests were carried out in GraphPad Prism (version 7).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!